RAC 0.58% $1.74 race oncology ltd

Ann: Race Board and Management Team Changes, page-353

  1. 1,965 Posts.
    lightbulb Created with Sketch. 328
    In the new format, it would've as it wouldn't have qualified under the 505b2, as Zantrene would've been dosed in combo.. So they would've had to go through the whole clinical pathway.

    ill be interested to see what they will do with AML now.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.